AGP Executive Report
Last update: 4 hours agoAlzheimer’s Prevention Trial (Roche): Roche’s Swiss-developed trontinemab is set to be tested in a Europe-first NHS-led study for people without symptoms but at high risk, using blood tests for the p-tau217 marker and enrolling about 1,600 adults across UK sites and beyond. CERN IT Migration (Switzerland): CERN engineers in Winterthur plan to move more than 2,200 specialized computers from Red Hat Enterprise Linux to Debian to keep older hardware usable for future particle-physics runs. Swiss Drone Aid (Nepal): Switzerland provided Nepal’s rescue teams with a Flyability “Flyability” tunnel-capable drone to improve search-and-rescue and inspection in hazardous hydropower tunnels. Biotech Deal Watch (Novartis): Novartis’ $2B+ acquisition of London-based Myricx is drawing attention from Australian biotech investors as the sector faces a looming patent cliff. Space Safety: A new look at satellite crowding highlights rising orbital collision risks as the number of objects in Earth’s orbit keeps climbing.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
